Literature DB >> 15705349

Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats.

William A Carlezon1, Stephen D Mague, Aimee M Parow, Andrew L Stoll, Bruce M Cohen, Perry F Renshaw.   

Abstract

BACKGROUND: Brain phospholipid metabolism and membrane fluidity may be involved in the pathophysiology of mood disorders. We showed previously that cytidine, which increases phospholipid synthesis, has antidepressant-like effects in the forced swim test (FST) in rats, a model used in depression research. Because cytidine and uridine both stimulate synthesis of cytidine 5'-diphosphocholine (CDP-choline, a critical substrate for phospholipid synthesis), we examined whether uridine would also produce antidepressant-like effects in rats. We also examined the effects of omega-3 fatty acids (OMG), which increase membrane fluidity and reportedly have antidepressant effects in humans, alone and in combination with uridine.
METHODS: We first examined the effects of uridine injections alone and dietary supplementation with OMG alone in the FST. We then combined sub-effective treatment regimens of uridine and OMG to determine whether these agents would be more effective if administered together.
RESULTS: Uridine dose-dependently reduced immobility in the FST, an antidepressant-like effect. Dietary supplementation with OMG reduced immobility when given for 30 days, but not for 3 or 10 days. A sub-effective dose of uridine reduced immobility in rats given sub-effective dietary supplementation with OMG.
CONCLUSIONS: Uridine and OMG each have antidepressant-like effects in rats. Less of each agent is required for effectiveness when the treatments are administered together.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705349     DOI: 10.1016/j.biopsych.2004.11.038

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  48 in total

1.  Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T.

Authors:  Nivedita Agarwal; Young-Hoon Sung; J Eric Jensen; Grace daCunha; David Harper; David Olson; Perry F Renshaw
Journal:  Bipolar Disord       Date:  2010-12       Impact factor: 6.744

Review 2.  Inflammation: depression fans the flames and feasts on the heat.

Authors:  Janice K Kiecolt-Glaser; Heather M Derry; Christopher P Fagundes
Journal:  Am J Psychiatry       Date:  2015-09-11       Impact factor: 18.112

3.  Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial.

Authors:  Marlene P Freeman; Joseph R Hibbeln; Michael Silver; April M Hirschberg; Betty Wang; Amy M Yule; Laura F Petrillo; Erica Pascuillo; Nicole I Economou; Hadine Joffe; Lee S Cohen
Journal:  Menopause       Date:  2011-03       Impact factor: 2.953

4.  Selective inhibition of intestinal 5-HT improves neurobehavioral abnormalities caused by high-fat diet mice.

Authors:  Qi Pan; Qiongzhen Liu; Renling Wan; Praveen Kumar Kalavagunta; Li Liu; Wenting Lv; Tong Qiao; Jing Shang; Huali Wu
Journal:  Metab Brain Dis       Date:  2019-04-01       Impact factor: 3.584

5.  Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency.

Authors:  Corina O Bondi; Ameer Y Taha; Jody L Tock; Nelson K B Totah; Yewon Cheon; Gonzalo E Torres; Stanley I Rapoport; Bita Moghaddam
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

6.  Computational (DFT and TD DFT) study of the electron structure of the tautomers/conformers of uridine and deoxyuridine and the processes of intramolecular proton transfers.

Authors:  Vassil B Delchev
Journal:  J Mol Model       Date:  2009-10-10       Impact factor: 1.810

Review 7.  Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.

Authors:  Erik Messamore; Daniel M Almeida; Ronald J Jandacek; Robert K McNamara
Journal:  Prog Lipid Res       Date:  2017-01-06       Impact factor: 16.195

8.  Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder.

Authors:  Robert K McNamara; Jennifer Strimpfel; Ronald Jandacek; Therese Rider; Patrick Tso; Jeffrey A Welge; Jeffrey R Strawn; Melissa P Delbello
Journal:  PharmaNutrition       Date:  2014-04-01

9.  Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats.

Authors:  Robert K McNamara; Jessica A Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Jack W Lipton
Journal:  Pharmacol Biochem Behav       Date:  2013-10-01       Impact factor: 3.533

10.  Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition.

Authors:  Marwa A Aboukhatwa; Ashiwel S Undieh
Journal:  BMC Neurosci       Date:  2010-01-27       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.